The ARTS, ARTS-HF, and ARTS-DN studies have validated its advantages for heart failure and diabetic nephropathy patients while emphasizing its superior safety profile compared to steroidal mineralocorticoid receptor antagonists, particularly in terms of hyperkalemia. This evidence concerns the gene NR3C2 and hydrops fetalis.